Drugmaker Patent Accords Delaying Generics Up 63%, FTC Says

keep generics off the market are already costing consumers and taxpayers $3.5 billion a year in higher drug prices,��� Leibowitz said today in a statement. ���The increasing number of these deals is a win-win proposition for the pharmaceutical industry,...